Depression of mGluR-mediated IPSCs by 5-HT in dopamine neurons of the rat substantia nigra pars compacta

European Journal of Neuroscience

Volumn 18, Issue 10, 2003, Pages 2743-2750

  Paolucci, E ^a,b   Berretta, N ^a   Tozzi, A ^a   Bernardi, G ^a,b   Mercuri, N B ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

5 HT2 receptors; 5 HT4 receptors; Basal ganglia; SK channels

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 3 PIPERIDINOPROPYL ESTER; 5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; 8 [4 (5 AMINO 2,4 DIMETHOXYBENZOYL)BUTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; ALPHA METHYLSEROTONIN; CALCIUM; CINANSERIN; METABOTROPIC RECEPTOR; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DORSAL RAPHE NUCLEUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MESENCEPHALON; NERVE CELL EXCITABILITY; NERVE PROJECTION; NEUROMODULATION; NONHUMAN; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEROTONINERGIC SYSTEM; SUBSTANTIA NIGRA; SYNAPSE;

ANIMALS; ANIMALS, NEWBORN; APAMIN; CALCIUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; MEMBRANE POTENTIALS; METHOXYHYDROXYPHENYLGLYCOL; NEURAL CONDUCTION; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; SEROTONIN; SEROTONIN AGENTS; SUBSTANTIA NIGRA; VALINE;

EID: 0346120434     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2003.03015.x     Document Type: Article

References (51)

1. Abdel-Latif, A.A. (2001) Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp. Biol. Med., 226, 153-163.
2. Andrade, R. & Chaput, Y. (1991) 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J. Pharmacol. Exp. Ther., 257, 930-937.
3. Azmitia, E.C. & Whitaker-Azmitia, P.M. (1995) Anatomy, cell biology, and plasticity of the serotonergic system: neuropharmacological implications for the action of psychotropic drugs. In Bloom, F.E. & Kupfler, D.J. (eds), Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York, pp. 443-449.
4. Barnes, N.M. & Sharp, T. (1999) A review of central 5-HT receptors and their function. Neuropharmacology, 38, 1083-1152.
5. Baxter, G., Kennett, G., Blaney, F. & Blackburn, T. (1995) 5-HT2 receptor subtypes: a family re-united? Trends Pharmacol. Sci., 16, 105-110.
6. Bevan, M., Magill, P., Terman, D., Bolam, J. & Wilson, C. (2002) Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci., 25, 525.
7. Boess, F.G. & Martin, I.L. (1994) Molecular biology of 5-HT receptors. Neuropharmacology, 33, 275-317.
8. Bonhaus, D.W., Weinhardt, K.K., Taylor, M., DeSouza, A., McNeeley, P.M., Szczepanski, K., Fontana, D.J., Trinh, J., Rocha, C.L., Dawson, M.W., Flippin, L.A. & Eglen, R.M. (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology, 36, 621-, 629.
9. Colquhoun, D. (1998) Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br. J. Pharmacol., 125, 924-947.
10. Conn, P.J. & Sanders-Bush, E. (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors. J. Pharmacol. Exp. Ther., 242, 552-557.
11. Di Matteo, V., De Blasi, A., Di Giulio, C. & Esposito, E. (2001) Role of 5-HT (2C) receptors in the control of central dopamine function. Trends Pharmacol. Sci., 22, 229-232.
12. Eglen, R.M., Bley, K., Bonhaus, D.W., Clark, R.D., Hegde, S.S., Johnson, L.G., Leung, E. & Wong, E.H. (1993) RS 23597-190: a potent and selective 5-HT4 receptor antagonist. Br. J. Pharmacol., 110, 119-126.
13. Eglen, R.M., Wong, E.H., Dumuis, A. & Bockaert, J. (1995) Central 5-HT4 receptors. Trends Pharmacol. Sci., 16, 391-398.
14. Fiorillo, C.D. & Williams, J.T. (1998) Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature, 394, 78-82.
15. Fiorillo, C.D. & Williams, J.T. (2000) Cholinergic inhibition of ventral midbrain dopamine neurons. J. Neurosci., 20, 7855-7860.
16. Francken, B.J., Josson, K., Lijnen, P., Jurzak, M., Luyten, W.H. & Leysen, J.E. (2000) Human 5-hydroxytryptamine (5A) receptors activate coexpressed G (i) and G (o) proteins in Spodoptera frugiperda 9 cells. Mol. Pharmacol., 57, 1034-1044.
17. Gerald, C., Adham, N., Kao, H.T., Olsen, M.A., Laz, T.M., Schechter, L.E., Bard, J.A., Vaysse, P.J., Hartig, P.R. & Branchek, T.A. (1995) The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J., 14, 2806-2815.
18. Gervais, J. & Rouillard, C. (2000) Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse, 35, 281-291.
19. Goaillard, J.M. & Vincent, P. (2002) Serotonin suppresses the slow after-hyperpolarization in rat intralaminar and midline thalamic neurones by activating 5-HT (7) receptors. J. Physiol. (Lond.), 541, 453-465.
20. Gobert, A., Rivet, J.M., Lejeune, F., Newman-Tancredi, A., Adhumeau-Auclair, A., Nicolas, J.P., Cistarelli, L., Melon, C. & Millan, M.J. (2000) Serotonin (2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse, 36, 205-221.
21. Grillner, P. & Mercuri, N.B. (2002) Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. Behav. Brain Res., 130, 149-169.
22. Grimaldi, B., Bonnin, A., Fillion, M.P., Ruat, M., Traiffort, E. & Fillion, G. (1998) Characterization of 5-ht6 receptor and expression of 5-ht6 mRNA in the rat brain during ontogenetic development. Naunyn Schmiedeberg's Arch. Pharmacol., 357, 393-400.
23. Grossman, C.J., Kilpatrick, G.J. & Bunce, K.T. (1993) Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br. J. Pharmacol., 109, 618-624.
24. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R. & Humphrey, P.P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
25. Ikemoto, K., Nishimura, A., Okado, N., Mikuni, M., Nishi, K. & Nagatsu, I. (2000) Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration. Brain Res., 853, 377-380.
26. Ismaiel, A.M., Titeler, M., Miller, K.J., Smith, T.S. & Glennon, R.A. (1990) 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin. J. Med. Chem., 33, 755-758.
27. Jakeman, L.B., To, Z.P., Eglen, R.M., Wong, E.H. & Bonhaus, D.W. (1994) Quantitative autoradiography of 5-HT4 receptors in brains of three species using two structurally distinct radioligands, [3H]GR113808 and [3H]BIMU-1. Neuropharmacology, 33, 1027-1038.
28. Jenkinson, D.H. (1996) Classical approaches to the study of drug-receptor interactions. In: Foreman, J.C. & Johansen, T., eds. Textbook of Receptor Pharmacology. CRC Press, London, pp. 3-64.
29. Johnson, S.W., Mercuri, N.B. & North, R.A. (1992) 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons. J. Neurosci., 12, 2000-2006.
30. Lucas, G., Di Matteo, V., De Deurwaerdere, P., Porras, G., Martin-Ruiz, R., Artigas, F., Esposito, E. & Spampinato, U. (2001) Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. Eur. J. Neurosci., 13, 889-898.
31. Overton, P.G. & Clark, D. (1997) Burst firing in midbrain dopaminergic neurons. Brain Res. Brain Res. Rev., 25, 312-334.
32. Paladini, C.A., Fiorillo, C.D., Morikawa, H. & Williams, J.T. (2001) Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons. Nature Neurosci., 4, 275-281.
33. Pazos, A., Cortes, R. & Palacios, J.M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res., 346, 231-249.
34. Pazos, A. & Palacios, J.M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res., 346, 205-230.
35. Pierce, P.A., Kim, J.Y. & Peroutka, S.J. (1992) Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors. Naunyn Schmiedeberg's Arch. Pharmacol., 346, 4-11.
36. Plassat, J.L., Amlaiky, N. & Hen, R. (1993) Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol., 44, 229-236.
37. Pompeiano, M., Palacios, J.M. & Mengod, G. (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res. Mol. Brain Res., 23, 163-178.
38. Porras, G., Di Matteo, V., De Deurwaerdere, P., Esposito, E. & Spampinato, U. (2002a) Central serotonin (4) receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine. Neuropharmacology, 43, 1099-1109.
39. Porras, G., Di Matteo, V., Fracasso, C., Lucas, G., De Deurwaerdere, P., Caccia, S., Esposito, E. & Spampinato, U. (2002b) 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology, 26, 311-324.
40. Porter, R.H., Benwell, K.R., Lamb, H., Malcolm, C.S., Allen, N.H., Revell, D.F., Adams, D.R. & Sheardown, M.J. (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br. J. Pharmacol., 128, 13-20.
41. Pozzi, L., Trabace, L., Invernizzi, R. & Samanin, R. (1995) Intranigral GR-113808, a selective 5-HT4 receptor antagonist, attenuates morphine-stimulated dopamine release in the rat striatum. Brain Res., 692, 265-268.
42. Prisco, S., Pagannone, S. & Esposito, E. (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J. Pharmacol. Exp. Ther., 271, 83-90.
43. Rick, C.E., Stanford, I.M. & Lacey, M.G. (1995) Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors. Neuroscience, 69, 903-913.
44. Sah, P. (1996) Ca (2+)-activated K+ currents in neurones: types, physiological roles and modulation. Trends Neurosci., 19, 150-154.
45. Stanford, I.M. & Lacey, M.G. (1996) Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J. Neurosci., 16, 7566-7573.
46. Thorre, K., Ebinger, G. & Michotte, Y. (1998) 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study. Brain Res., 796, 117-124.
47. Tong, Z.Y., Overton, P.G. & Clark, D. (1996) Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events. Synapse, 22, 195-208.
48. Tozzi, A., Guatteo, E., Caputi, L., Bernardi, G. & Mercuri, N.B. (2001) Group I mGluRs coupled to G proteins are regulated by tyrosine kinase in dopamine neurons of the rat midbrain. J. Neurophysiol., 85, 2490-2497.
49. Waeber, C., Sebben, M., Grossman, C., Javoy-Agid, F., Bockaert, J. & Dumuis, A. (1993) [3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain. Neuroreport, 4, 1239-1242.
50. Wichmann, T., Kliem, M.A. & Soares, J. (2002) Slow oscillatory discharge in the primate Basal Ganglia. J, Neurophysiol., 87, 1145-1148.
51. Wolfart, J., Neuhoff, H., Franz, O. & Roeper, J. (2001) Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J. Neurosci., 21, 3443-3456.